These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11920590)

  • 1. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
    Fiedler T; Walter W; Reichert TE; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice.
    Chen YH; Wang B; Chun T; Zhao L; Cardell S; Behar SM; Brenner MB; Wang CR
    J Immunol; 1999 Apr; 162(8):4560-6. PubMed ID: 10201995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function.
    Sundararaj S; Zhang J; Krovi SH; Bedel R; Tuttle KD; Veerapen N; Besra GS; Khandokar Y; Praveena T; Le Nours J; Matsuda JL; Rossjohn J; Gapin L
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1204-E1213. PubMed ID: 29351991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse TCRs recognize murine CD1.
    Behar SM; Podrebarac TA; Roy CJ; Wang CR; Brenner MB
    J Immunol; 1999 Jan; 162(1):161-7. PubMed ID: 9886382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of a novel subset of NKT cells bearing an invariant V(alpha)19.1-J(alpha)26 TCR alpha chain.
    Shimamura M; Huang YY
    FEBS Lett; 2002 Apr; 516(1-3):97-100. PubMed ID: 11959111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
    Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L
    Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo.
    Renukaradhya GJ; Sriram V; Du W; Gervay-Hague J; Van Kaer L; Brutkiewicz RR
    Int J Cancer; 2006 Jun; 118(12):3045-53. PubMed ID: 16395717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis.
    Campos-Martín Y; Gómez del Moral M; Gozalbo-López B; Suela J; Martínez-Naves E
    J Immunol; 2004 Jun; 172(12):7297-305. PubMed ID: 15187105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments.
    Chiu YH; Jayawardena J; Weiss A; Lee D; Park SH; Dautry-Varsat A; Bendelac A
    J Exp Med; 1999 Jan; 189(1):103-10. PubMed ID: 9874567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1.
    Huang MM; Borszcz P; Sidobre S; Kronenberg M; Kane KP
    J Immunol; 2004 May; 172(9):5304-12. PubMed ID: 15100269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells.
    Mempel M; Ronet C; Suarez F; Gilleron M; Puzo G; Van Kaer L; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2002 Jan; 168(1):365-71. PubMed ID: 11751982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.